Sir, Little is known about the emergence and dissemination of metallo-b-lactamase (MBL)-producing Pseudomonas aeruginosa in Germany. In the last decade only a few sporadic cases have been reported. In 2004 the detection of the unique MBL-type GIM-1 in five identical P. aeruginosa isolates from a German hospital was described. 1 Several reports on P. aeruginosa possessing the MBLs VIM-1, VIM-2 and VIM-16 were published in 2005 and 2008. 2, 3 Here we report on the molecular characterization of GIM-1 and VIM MBLs in clinical isolates of P. aeruginosa.
Between March 2009 and August 2010 we isolated 3000 clinical strains of P. aeruginosa from 37 hospitals in the federal state of North Rhine-Westphalia, Germany. Included in the present study were all multidrug-resistant P. aeruginosa isolates showing resistance to penicillins (piperacillin/tazobactam), cephalosporins (ceftazidime) and fluoroquinolones (ciprofloxacin) and being additionally resistant to carbapenems (imipenem and meropenem). Among the 3000 isolates, 18 (0.6%) consecutive non-duplicate strains were found fulfilling the criteria. Furthermore, these isolates were resistant to gentamicin but remained susceptible to polymyxin B. MBL production was confirmed for 8 of the 18 P. aeruginosa isolates by Etest MBL (bioMér-ieux, Nü rtingen, Germany).
Molecular screening was performed for the common MBL genes bla IMP , bla VIM and bla NDM-1 and for the locally occurring genes bla GIM , bla SPM and bla SIM . 4 Since most MBL genes are integrated at specific sites in class 1 integrons (int1), the gene sequence of the variable region was determined by PCR mapping.
PCR and sequencing of relevant MBL genes revealed the presence of bla GIM-1 in five isolates, bla VIM-2 in two isolates and bla VIM-16 in one isolate. PCR mapping analyses showed that all MBL genes were located within different gene cassettes embedded in class 1 integrons (Figure 1 ). The nucleotide sequences of the bla GIM-1 -containing integron structures have been registered in the GenBank database under accession numbers GU390399, GU390401, GU390404, GU390403 and JF414726.
Transfer of b-lactam resistance was performed by broth mating assays using the GIM-1-producing P. aeruginosa isolates and a sodium azide-resistant Escherichia coli J53 recipient. However, we did not obtain any transconjugants. Furthermore, transformation of plasmids isolated from all GIM-1-producing P. aeruginosa isolates using the Qiagen Plasmid Mini Kit (Qiagen, Hilden, Germany) into the electrocompetent recipients P. aeruginosa ATCC 27853 and P. aeruginosa NCTC 10662 was unsuccessful. 5 These observations correspond to the report of the first P. aeruginosa isolate from 2002 describing the detection of bla GIM-1 on a non-transferable plasmid. 1 The two P. aeruginosa isolates in the present study harbouring bla VIM-2 showed integron structures identical to those that were recently described in outbreak strains from Greece, designated as In59.2.
6 Both strains were recovered from two hospitals within the city of Cologne. However, both strains showed identical macrorestriction patterns in PFGE analysis (data not shown). In another P. aeruginosa (MG1222) we identified the MBL gene bla VIM-16 . The int1 structure corresponded with a partially sequenced integron from a P. aeruginosa strain isolated in Munich, Germany, in 2005. 3 Additional strain typing by PFGE revealed that P. aeruginosa MG1222 and the strain from Munich are very closely related.
The P. aeruginosa isolates MG1370 and MG3918 showed different macrorestriction patterns but identical gene cassettes, with bla GIM-1 inserted at the first position. Downstream, three aminoglycoside resistance genes were identified: the adenylyltransferase gene aadB and the two acetyltransferase genes aacC and aacA7 (Figure 1a) .
The int1 structures of two further GIM-1-producing P. aeruginosa strains (MG3404 and MG2736) were related to each other and both lacked the genes aacC and aacA7 (Figure 1b) . The isolates had identical PFGE patterns but showed no genetic relationships to the other GIM-1-producing strains. Both strains were isolated in two different hospitals in Mö nchengladbach, Germany.
Sequence analysis of the fifth isolate (MG4737) harbouring bla GIM-1 revealed a cassette array identical to that found in the first isolated GIM-1-producing P. aeruginosa strain in 2002 in Dü sseldorf, Germany (Figure 1c) . 1 The PFGE pattern of isolate MG4737 was unique compared with the other four isolates. Unfortunately, there was no opportunity to investigate the clonal relatedness with the strain from the outbreak in 2002.
In the present study we found MBL in 8 of 18 carbapenemresistant P. aeruginosa isolates, indicating that other resistance mechanisms, such as up-regulated efflux, are more prevalent than MBL production in this species. The five bla GIM-1 -containing P. aeruginosa strains were found in hospitals in four different cities within a radius of 40 km around Dü sseldorf, the place where the first GIM-1-producing isolate was detected 9 years ago. The clonal diversity of strains with an identical integron structure indicates the capability to spread. Although the detection rate is likely underestimated, the occurrence of GIM-1 seems to be localized, in contrast to VIM-type MBL, which also occur in other parts of Germany. Thus, further molecular epidemiological investigations are needed to increase knowledge about the frequency, geographical distribution and origin of MBL-producing strains in Germany. 
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Modified Hodge tests were performed on 12 isolates; 11 were negative and 1 was positive. The positive isolate was an Enterobacter cloacae with a Vitek 2 MIC of 8 mg/L and an Etest MIC of 32 mg/L. The meropenem Etest MIC range for isolates that had a 
